[HTML][HTML] Th17-related cytokines: new players in the control of chronic intestinal inflammation

I Monteleone, F Pallone, G Monteleone - BMC medicine, 2011 - Springer
Crohn's disease (CD) and ulcerative colitis (UC), the main forms of inflammatory bowel
diseases (IBD) in man, are thought to be caused by an excessive and poorly controlled …

Risks and benefits of biologic therapy for inflammatory bowel diseases

G D'Haens - Gut, 2007 - gut.bmj.com
The advent of biological drugs has had a significant impact on the management of
inflammatory bowel diseases. For an important group of patients with Crohn's disease and …

Neuroprotective intervention by interferon-γ blockade prevents CD8+ T cell–mediated dendrite and synapse loss

M Kreutzfeldt, A Bergthaler, M Fernandez… - Journal of Experimental …, 2013 - rupress.org
Neurons are postmitotic and thus irreplaceable cells of the central nervous system (CNS).
Accordingly, CNS inflammation with resulting neuronal damage can have devastating …

Inflammation in the intestinal tract: pathogenesis and treatment

RS Blumberg - Digestive diseases, 2009 - karger.com
Over the past decade a major hypothesis has emerged for the etiopathogenesis of
inflammatory bowel disease (IBD). This hypothesis proposes that IBD represents a …

Targeting the development and effector functions of TH17 cells

N Ghilardi, W Ouyang - Seminars in immunology, 2007 - Elsevier
T helper (TH) cells can assume different phenotypes characterized by the secretion of
distinct effector molecules. Interferon-γ producing TH1 and IL-4 producing TH2 cells have …

Current status and challenges of cytokine pharmacology

Z Zidek, P Anzenbacher… - British journal of …, 2009 - Wiley Online Library
The major concern of pharmacology about cytokines has originated from plentiful data
showing association between gross changes in their production and pathophysiological …

[HTML][HTML] Osteoporosis and gastrointestinal disease

S Katz, S Weinerman - Gastroenterology & hepatology, 2010 - ncbi.nlm.nih.gov
Gastrointestinal disease is often overlooked or simply forgotten as a cause of osteoporosis.
Yet, the consequences of osteoporotic fractures can be devastating. Although the bulk of the …

Trial watch: immunostimulatory cytokines

E Vacchelli, L Galluzzi, A Eggermont, J Galon… - …, 2012 - Taylor & Francis
During the last two decades, a number of approaches for the activation of the immune
system against cancer has been developed. These include highly specific interventions …

Crohn's disease: beyond antagonists of tumour necrosis factor

L Peyrin-Biroulet, P Desreumaux, WJ Sandborn… - The Lancet, 2008 - thelancet.com
In the past few years, antagonists of tumour necrosis factor have resulted in unforetold
therapeutic benefits in Crohn's disease, but the magnitude and duration of responses are …

Innate lymphoid cells in inflammatory bowel diseases

CP Peters, JM Mjösberg, JH Bernink, H Spits - Immunology letters, 2016 - Elsevier
It is generally believed that inflammatory bowel diseases (IBD) are caused by an aberrant
immune response to environmental triggers in genetically susceptible individuals. The exact …